Compare Stocks

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CIA Citizens	$2.00 +1.5%	$2.39	$1.64 ▼ $3.69	$99.14M	0.19	52,683 shs	39,290 shs
HOC Hunter Technology	C$0.15 -21.1%	C$0.15	C$0.12 ▼ C$0.91	C$340K	5.54	7,770 shs	1,000 shs
MGX Metagenomi	$8.25 -0.2%	$11.00	$8.10 ▼ $12.74	$309.14M	N/A	172,765 shs	146,909 shs

Metaverse Stocks And Why You Can't Ignore Them

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CIA Citizens	-0.50%	-2.44%	-9.91%	-20.32%	-14.16%
HOC Hunter Technology	0.00%	0.00%	0.00%	0.00%	-37.50%
MGX Metagenomi	-0.24%	-12.23%	-25.47%	+824,999,900.00%	+824,999,900.00%

The “Perfect Storm” for Gold (Ad)

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CIA Citizens	0.3333 of 5 stars	0.0	0.0	0.0	0.0	2.4	1.7	1.9
HOC Hunter Technology	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MGX Metagenomi	2.23 of 5 stars	4.5	0.0	0.0	0.0	0.6	1.7	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CIA Citizens	N/A	N/A	N/A	N/A
HOC Hunter Technology	N/A	N/A	N/A	N/A
MGX Metagenomi	3.00	Buy	$21.40	159.39% Upside

Current Analyst Ratings

Latest SXX, HOC, CIA, and MGX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/28/2024	MGX Metagenomi	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$21.00
3/5/2024	MGX Metagenomi	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform
3/5/2024	MGX Metagenomi	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$22.00
3/5/2024	MGX Metagenomi	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$16.00
3/5/2024	MGX Metagenomi	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$23.00
3/5/2024	MGX Metagenomi	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$21.00
3/5/2024	MGX Metagenomi	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$25.00

(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CIA Citizens	$240.68M	0.41	$0.62 per share	3.23	$3.47 per share	0.58
HOC Hunter Technology	C$-431K	-0.79	C$0.01 per share	28.75	C($0.35) per share	-0.43
MGX Metagenomi	$44.76M	6.91	N/A	N/A	N/A	∞

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CIA Citizens	$24.44M	$0.48	4.17	∞	N/A	10.15%	15.61%	1.50%	5/13/2024 (Estimated)
HOC Hunter Technology	-C$8.84M	-C$0.15	N/A	∞	N/A	N/A	-241.99%	-350.90%	N/A
MGX Metagenomi	-$68.25M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	6/26/2024 (Estimated)

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CIA Citizens	N/A	N/A	N/A	N/A	N/A
HOC Hunter Technology	N/A	N/A	N/A	N/A	N/A
MGX Metagenomi	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CIA Citizens	N/A	0.04	0.04
HOC Hunter Technology	0.96	0.01	0.04
MGX Metagenomi	N/A	4.04	4.04

Ownership

Institutional Ownership

Company	Institutional Ownership
CIA Citizens	13.73%
HOC Hunter Technology	0.77%
MGX Metagenomi	N/A

Insider Ownership

Company	Insider Ownership
CIA Citizens	0.88%
HOC Hunter Technology	17.64%
MGX Metagenomi	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
CIA Citizens	232	49.57 million	49.14 million	Optionable
HOC Hunter Technology	N/A	2.27 million	N/A	Not Optionable
MGX Metagenomi	236	37.47 million	N/A	N/A

SXX, HOC, CIA, and MGX Headlines

Source	Headline
	Metagenomi to Present at Upcoming Scientific Meetings globenewswire.com - April 8 at 8:00 AM
	Metagenomi, Inc. Expected to Earn FY2024 Earnings of ($2.44) Per Share (NASDAQ:MGX) marketbeat.com - April 4 at 9:14 AM
	Metagenomi (NASDAQ: MGX) fool.com - April 3 at 3:54 AM
	Metagenomi Inc MGX morningstar.com - April 2 at 5:53 PM
	Metagenomi, Inc.: Strong Buy Rating on Robust Hemophilia Program and Strategic Partnerships markets.businessinsider.com - March 29 at 4:47 AM
	Metagenomi, Inc.: Strong Buy Rating on Promising Pipeline and Solid Financial Positioning markets.businessinsider.com - March 29 at 4:47 AM
	Metagenomi, Inc.: Metagenomi Reports Business Updates and Full Year 2023 Financial Results finanznachrichten.de - March 28 at 6:44 PM
	Metagenomi (NASDAQ:MGX) Stock Rating Reaffirmed by Chardan Capital marketbeat.com - March 28 at 8:28 AM
	Metagenomi reports FY results msn.com - March 27 at 12:31 PM
	Metagenomi Reports Business Updates and Full Year 2023 Financial Results globenewswire.com - March 27 at 9:16 AM
	Metagenomi to Participate in the 44th Annual Cowen Healthcare Conference globenewswire.com - February 29 at 4:30 PM
	This Biotech IPO Stock Just Took a Tumble, But Don't Give Up on It Yet fool.com - February 19 at 10:30 AM
	Insider Buying: Taking a Controlling Stake in a Struggling Retailer? 247wallst.com - February 18 at 11:20 AM
	Metagenomi Announces Closing of Initial Public Offering globenewswire.com - February 13 at 4:35 PM
	Moderna, Bayer-backed Metagenomi stock drops 32% on Nasdaq debut reuters.com - February 9 at 2:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
April 2, 2024 9:15 AM
View Canoo, Inc. Bites the Dust: Mullen Automotive Is a Better Bet
3 Cheap Stocks That Shouldn’t Be Cheap for Long
March 26, 2024 9:49 AM
View 3 Cheap Stocks That Shouldn’t Be Cheap for Long
How to Protect your Portfolio Against a Rising VIX
April 10, 2024 9:22 AM
View How to Protect your Portfolio Against a Rising VIX
Low Interest Rates Can Help These Commercial Banks Rally Higher
April 2, 2024 11:38 AM
View Low Interest Rates Can Help These Commercial Banks Rally Higher

All Headlines

Company Descriptions

Citizens

NYSE:CIA

Citizens, Inc. provides life insurance products in the United States and internationally. The company operates in two segments, Life Insurance and Home Service Insurance. The Life Insurance segment issues ordinary whole life insurance and endowment policies in the United States dollar-denominated amounts to non-U.S. residents in through independent marketing agencies and consultants. The Home Service Insurance segment offers final expense life insurance and property insurance policies to middle-and lower-income households, as well as whole life products in Louisiana, Mississippi, and Arkansas. This segment provides its products and services through funeral homes and independent agents. The company provides accident and health insurance policies. Citizens, Inc. was founded in 1969 and is headquartered in Austin, Texas.

Hunter Technology

CVE:HOC

Hunter Technology Corp. focuses on the development, operation, and management of digital platforms for energy resources in Canada. It offers OilEx, a blockchain-based marketplace for hydrocarbons that enables international buyers of physical oil to connect with independent crude oil producers in a global market. The company also provides OilExchange, a supply chain intelligence service that provides a full suite of data collection, monitoring, and analytics functions enabling a real-time view along the physical oil trading supply chain. Hunter Technology Corp. has a strategic partnership with WellDatabase that allows the company to integrate with WellDatabase's operational E&P data from across the United States and Canada. The company was formerly known as Hunter Oil Corp. and changed its name to Hunter Technology Corp. in November 2020. Hunter Technology Corp. was incorporated in 1980 and is headquartered in Vancouver, Canada.

Metagenomi

NASDAQ:MGX

Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. The company's genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and clustered regularly interspaced short palindromic repeat-associated transposases. It has a strategic collaboration and license agreement with ModernaTX, Inc. focusing on new genome editing system for in vivo human therapeutic applications; a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited T-cell receptor-based therapeutic products in the field of treatment, prevention, or diagnosis of human cancer; and a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop, and commercialize investigational medicines using genome editing technologies. The company was incorporated in 2016 and is based in Emeryville, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial